Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia.

PloS one - 1 Jan 2013

Aponte-González Johanna, Fajardo-Bernal Luisa, Diaz Jorge, Eslava-Schmalbach Javier, Gamboa Oscar, Hay Joel W

Abstract excerpt

OBJECTIVE: To compare costs and effectiveness of three strategies used against cervical cancer (CC) and genital warts: (i) Screening for CC; (ii) Bivalent Human Papillomavirus (HPV) 16/18 vaccine added to screening; (iii) Quadrivalent HPV 6/11/16/18 vaccine added to screening. METHODS: A Markov m...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alphapapillomavirus
Share to Colombia
Share to Condylomata Acuminata

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cost-Benefit Analysis

Share to Markov Chains

Share to Papillomavirus Vaccines

Share to Registries

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 24260441
DOI: 10.1371/journal.pone.0080639
PMCID: PMC3832449

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24260441-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia.PMID 24260441Read ↗

Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the NetherlandsSemantic proximity Read ↗

Cost Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16, 18 VaccinationSemantic proximity Read ↗

Cost-Effectiveness and Budget Impact Analysis of Primary Screening With Human Papillomavirus Test With Genotyping in Argentina.Semantic proximity Read ↗

Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile.Semantic proximity Read ↗

Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries.Semantic proximity Read ↗

Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in SwazilandSemantic proximity Read ↗

Cost-effectiveness of HPV-based versus VIA-based cervical cancer screening among women living with HIV in Masaka District, UgandaSemantic proximity Read ↗

Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana.Semantic proximity Read ↗

The budget impact of cervical cancer screening using HPV primary screening.Semantic proximity Read ↗

Evaluating Cost-effectiveness of 9-valent HPV Vaccination for Men Who Have Sex with Men by HIV Status in Hong KongSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.